Cancer News and Research

Latest Cancer News and Research

BioInvent reports net revenues of SEK 63.1M for January - June 2010 period

BioInvent reached an important milestone when the results of a phase II trial of TB-402 following orthopaedic surgery, were reported in May. The data showed that TB-402 is statistically better at preventing thrombosis than enoxaparin, the current standard treatment. Supported by these good results, BioInvent and the company's partner, ThromboGenics, will now prioritise securing a development partner for the programme to ensure that the necessary resources is in place to take the product candidate to the market.

14 Jul 2010

First Lady, HHS Secretary to discuss new preventive health care coverage under Affordable Care Act

On Wednesday, at 2:15 PM EDT, First Lady Michelle Obama, Dr. Jill Biden, HHS Secretary Kathleen Sebelius will join doctors, nurses, families, and leaders from health community to make an announcement regarding new preventive health care coverage made available under the Affordable Care Act at George Washington University Hospital.

14 Jul 2010

Summer campaign to combat crimes against fashion, dangerous sunburn

FASHION-LOVING Brits have denounced 'socks and sandals' as the ultimate summer fashion faux pas, in a poll released today (13th July) to celebrate the launch of 'Fashion Forecast' from Cancer Research UK's SunSmart campaign and fashion retailer ASOS.com, which provides tailored online fashion advice to help people be stylish while avoiding sunburn this summer.

14 Jul 2010

Varian adopts Varicent for administering Sales Performance Management needs

Varicent Software Incorporated, the leading innovator in incentive compensation (ICM) and sales performance management (SPM) solutions, announced today that a business unit within Varian Medical Systems, the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions, has selected Varicent for administering its complex sales incentive compensation plans and sales performance management activities.

14 Jul 2010

Oncura signs distribution agreement with Theragenics for palladium-103 brachytherapy seeds

ONCURA, a business unit of GE Healthcare and global leader in the minimally invasive permanent prostate brachytherapy management of prostate cancer, has announced that it has signed an agreement to distribute Theragenics Corporation TheraSeed(R) palladium-103 brachytherapy seeds.

14 Jul 2010

No valid, adequate criteria for certifying an illness as terminal: Study

Physicians that have to decide whether an illness is terminal think that "there are not valid and adequate criteria for certifying that an illness is terminal". This is the conclusion drawn from a pioneer study conducted at the University of Granada, and recently published in the International Journal of Clinical and Health Psychology (IJCHP).

14 Jul 2010

Telecare management intervention improves pain, depression in cancer patients

Cancer patients receiving care in geographically dispersed urban and rural oncology practices who participated in a program that included telephone-based care management and home-based automated symptom monitoring had greater improvement in pain and depression compared to patients who received usual care, according to a study in the July 14 issue of JAMA.

14 Jul 2010

Cord Blood America to close BioCells acquisition by August end

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life-saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced that all preliminary due diligence is now complete for the acquisition of controlling interest in BioCells, Inc. BioCells is headquartered in Argentina, with affiliates under development in Peru, Colombia, Bolivia, Panama and Puerto Rico. The acquisition is expected to be closed no later than August 31, 2010.

14 Jul 2010

Report urges multi-disciplinary research approach to help HIV-positive women stay healthy

A report issued by the Program on International Health and Human Rights at the Harvard School of Public Health proposes a new research agenda to address the sexual and reproductive health and rights of HIV-positive women.

14 Jul 2010

Eban-based HIV/STD risk-reduction intervention improves safe-sex habits among high-risk African-American couples

A new study has found that heterosexual African American couples in which only one partner is HIV-positive practiced safer sexual behaviors after participating in a culturally specific intervention program designed to reduce the risk of HIV and other sexually transmitted diseases.

14 Jul 2010

IAS announces recipients of CNIHR grants

The International AIDS Society today announced the recipients of its first joint research grant programme, Creative and Novel Ideas in HIV Research. CNIHR grants, funded in partnership with the U.S. National Institutes of Health and the NIH-supported Centers for AIDS Research are designed to promote innovative research and new ideas from early stage investigators whose primary focus has previously been in fields of scientific inquiry other than HIV/ AIDS.

14 Jul 2010

Highlights of AAPM 52nd meeting

The 52nd meeting of the American Association of Physicists in Medicine (AAPM) convenes from July 18 - 22, 2010 in Philadelphia, PA.

14 Jul 2010

Exposure to cigarette smoke can alter gene expression, study finds

In the largest study of its kind, researchers at the Southwest Foundation for Biomedical Research have found that exposure to cigarette smoke can alter gene expression -- the process by which a gene's information is converted into the structures and functions of a cell. These alterations in response to smoking appear to have a wide-ranging negative influence on the immune system, and a strong involvement in processes related to cancer, cell death and metabolism.

14 Jul 2010

New prediction tool estimates risk for recurrence after breast-conserving surgery in DCIS patients

The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ (DCIS) has long been an area of discussion and confusion for patients and physicians alike. While the mortality rates for DCIS remain low, the risk of local recurrence in the breast is high. Standard treatments following surgery include radiation therapy and hormone treatment. While both treatments have been proven to lower the risk of recurrence in the breast, neither has been shown to improve survival, and both carry potentially serious risks.

14 Jul 2010

Improved delivery methods needed to advance gene therapy strategies for prostate cancer: Review

Improved delivery methods and better testing systems are needed to advance promising gene therapy strategies for treating prostate cancer, according to a series of review articles in Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc.

14 Jul 2010

Loyola primary care physicians honored with Blue Ribbon rating from Blue Cross and Blue Shield

Loyola University Health System primary care physicians recently received a Blue Ribbon rating from Blue Cross and Blue Shield. This honor is given to physicians who have received a satisfaction rate of 85 percent or higher based on a member survey.

14 Jul 2010

CTI signs agreement with NerPharMa for long-term manufacture of pixantrone

Cell Therapeutics today announced that it has signed a manufacturing agreement with NerPharMa DS (a pharmaceutical manufacturing company belonging to Nerviano Medical Sciences S.r.l. for CTI's drug candidate pixantrone.

14 Jul 2010

Protein discovery may lead to new cancer therapies

Researchers funded by the Medical Research Council (MRC) have discovered for the first time that two proteins called Mahjong and Lgl could be star players in helping to identify how the body's own cells fight back against cancer cells.

14 Jul 2010

Researchers examine long-term cause-specific mortality among childhood cancer survivors

Follow-up of a group of British childhood cancer survivors indicates they have an increased risk of death from second primary cancers and cardiac and cerebrovascular causes more than 25 years after their initial cancer diagnosis, according to a study in the July 14 issue of JAMA.

14 Jul 2010

CRT, MRCT to swap medical discoveries to advance translation of scientific research

Cancer Research Technology and Medical Research Council Technology will 'swap' medical discoveries to accelerate the translation of early scientific research into patient benefit.

14 Jul 2010

Cancer News and Research

Latest Cancer News and Research

BioInvent reports net revenues of SEK 63.1M for January - June 2010 period

First Lady, HHS Secretary to discuss new preventive health care coverage under Affordable Care Act

Summer campaign to combat crimes against fashion, dangerous sunburn

Varian adopts Varicent for administering Sales Performance Management needs

Oncura signs distribution agreement with Theragenics for palladium-103 brachytherapy seeds

No valid, adequate criteria for certifying an illness as terminal: Study

Telecare management intervention improves pain, depression in cancer patients

Cord Blood America to close BioCells acquisition by August end

Report urges multi-disciplinary research approach to help HIV-positive women stay healthy

Eban-based HIV/STD risk-reduction intervention improves safe-sex habits among high-risk African-American couples

IAS announces recipients of CNIHR grants

Highlights of AAPM 52nd meeting

Exposure to cigarette smoke can alter gene expression, study finds

New prediction tool estimates risk for recurrence after breast-conserving surgery in DCIS patients

Improved delivery methods needed to advance gene therapy strategies for prostate cancer: Review

Loyola primary care physicians honored with Blue Ribbon rating from Blue Cross and Blue Shield

CTI signs agreement with NerPharMa for long-term manufacture of pixantrone

Protein discovery may lead to new cancer therapies

Researchers examine long-term cause-specific mortality among childhood cancer survivors

CRT, MRCT to swap medical discoveries to advance translation of scientific research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in